HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Her, S. Articles by Wong, D. L. Search for Related Content PubMed PubMed Citation Articles by Her, S. Articles by Wong, D. L. Social Bookmarking                      What's this?

J Biol Chem, Vol. 274, Issue 13, 8698-8707, March 26, 1999

Phenylethanolamine N-Methyltransferase Gene Expression
SP1 AND MAZ POTENTIAL FOR TISSUE-SPECIFIC EXPRESSION

From the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California 94305-5485

Phenylethanolamine N-methyltransferase (PNMT) promoter-luciferase reporter gene constructs (pGL3RP863, pGL3RP444, and pGL3RP392) transfected into COS1, RS1, PC12, NIH/3T3, or Neuro2A cells showed the highest basal luciferase activity in the Neuro2A cells. DNase I footprinting with Neuro2A cell nuclear extract identified protected PNMT promoter regions spanning the -168/-165 and -48/-45 base pair Sp1/Egr-1 binding sites. Gel mobility shift assays and transient transfection assays using site-directed mutant PNMT promoter-luciferase reporter gene constructs indicated that the elevated basal luciferase activity in the Neuro2A cells was mediated by Sp-1. Furthermore, activation of the PNMT promoter by Sp1 depends on both its binding affinity for its cognate target sequences and its intracellular concentrations. When Sp1 levels were increased through an expression plasmid, luciferase reporter gene expression rose well beyond basal wild-type levels, even with either Sp1 binding element mutated. Finally, another transcription factor expressed in the Neuro2A cells competes with Sp1 by interacting with DNA sequences 3' to the -48 base pair Sp1 site to prevent Sp1 binding and induction of the PNMT promoter. The DNA consensus sequence, Southwestern analysis, and gel mobility shift assays with antibodies identify MAZ as the competitive factor. These findings suggest that Sp1 may potentially contribute to the tissue-specific expression of the PNMT gene, with the competition between Sp1 and MAZ conferring additional tissue-specific control.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				T. C. Tai, D. C. Wong-Faull, R. Claycomb, and D. L. Wong Nerve Growth Factor Regulates Adrenergic Expression Mol. Pharmacol., November 1, 2006; 70(5): 1792 - 1801. [Abstract] [Full Text] [PDF]

				A. Ray, D. Kumar, P. Ray, and B. K. Ray Transcriptional Activity of Serum Amyloid A-activating Factor-1 Is Regulated by Distinct Functional Modules J. Biol. Chem., December 24, 2004; 279(52): 54637 - 54646. [Abstract] [Full Text] [PDF]

				M. Adams, O. C. Meijer, J. Wang, A. Bhargava, and D. Pearce Homodimerization of the Glucocorticoid Receptor Is Not Essential for Response Element Binding: Activation of the Phenylethanolamine N-Methyltransferase Gene by Dimerization-Defective Mutants Mol. Endocrinol., December 1, 2003; 17(12): 2583 - 2592. [Abstract] [Full Text] [PDF]

				S. Her, R. Claycomb, T. C. Tai, and D. L. Wong Regulation of the Rat Phenylethanolamine N-Methyltransferase Gene by Transcription Factors Sp1 and MAZ Mol. Pharmacol., November 1, 2003; 64(5): 1180 - 1188. [Abstract] [Full Text] [PDF]

				A. Ray, P. Ray, N. Guthrie, A. Shakya, D. Kumar, and B. K. Ray Protein Kinase A Signaling Pathway Regulates Transcriptional Activity of SAF-1 by Unmasking Its DNA-binding Domains J. Biol. Chem., June 13, 2003; 278(25): 22586 - 22595. [Abstract] [Full Text] [PDF]

				B. K. Ray, R. Murphy, P. Ray, and A. Ray SAF-2, a Splice Variant of SAF-1, Acts as a Negative Regulator of Transcription J. Biol. Chem., November 22, 2002; 277(48): 46822 - 46830. [Abstract] [Full Text] [PDF]

				T. C. Tai, R. Claycomb, S. Her, A. K. Bloom, and D. L. Wong Glucocorticoid Responsiveness of the Rat Phenylethanolamine N-Methyltransferase Gene Mol. Pharmacol., June 1, 2002; 61(6): 1385 - 1392. [Abstract] [Full Text] [PDF]

				A. Ray, G.-Y. Yu, and B. K. Ray Cytokine-Responsive Induction of SAF-1 Activity Is Mediated by a Mitogen-Activated Protein Kinase Signaling Pathway Mol. Cell. Biol., February 15, 2002; 22(4): 1027 - 1035. [Abstract] [Full Text] [PDF]

				J. Aitsebaomo, M. L. Kingsley-Kallesen, Y. Wu, T. Quertermous, and C. Patterson Vezf1/DB1 Is an Endothelial Cell-specific Transcription Factor That Regulates Expression of the Endothelin-1 Promoter J. Biol. Chem., October 12, 2001; 276(42): 39197 - 39205. [Abstract] [Full Text] [PDF]

				B. K. Ray, J. Chen, and A. Ray Catalytic Subunit of Protein Kinase A Is an Interacting Partner of the Inflammation-Responsive Transcription Factor Serum Amyloid A-Activating Factor-1 J. Immunol., August 15, 2001; 167(4): 2343 - 2348. [Abstract] [Full Text] [PDF]

				G. Eisenhofer, M. M. Walther, T.-T. Huynh, S.-T. Li, S. R. Bornstein, A. Vortmeyer, M. Mannelli, D. S. Goldstein, W. M. Linehan, J. W. M. Lenders, et al. Pheochromocytomas in von Hippel-Lindau Syndrome and Multiple Endocrine Neoplasia Type 2 Display Distinct Biochemical and Clinical Phenotypes J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1999 - 2008. [Abstract] [Full Text]

				S. Uchida, Y. Tanaka, H. Ito, F. Saitoh-Ohara, J. Inazawa, K. K. Yokoyama, S. Sasaki, and F. Marumo Transcriptional Regulation of the CLC-K1 Promoter by myc-Associated Zinc Finger Protein and Kidney-Enriched Kruppel-Like Factor, a Novel Zinc Finger Repressor Mol. Cell. Biol., October 1, 2000; 20(19): 7319 - 7331. [Abstract] [Full Text]